Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse. Scope of the Report: This report focuses on the Narcolepsy Drug in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Jazz Pharmaceuticals Teva Pharmaceutical Novartis Mylan Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Antioxidants Type Stimulants Type Other Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 17 Chapters to deeply display the Europe Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Narcolepsy Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Narcolepsy Drug, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Narcolepsy Drug market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Narcolepsy Drug sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Narcolepsy Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Narcolepsy Drug Introduction 1.2 Market Analysis by Type 1.2.1 Antioxidants Type 1.2.2 Stimulants Type 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Daytime Extreme Sleepiness 1.3.2 Cataplexia 1.3.3 Others 1.4 Market Analysis by Countries 1.4.1 Germany Status and Pros
